In addition, cancer-promoted inflammation also plays a key role in determining CRC development [52], and inflammatory cytokines, such as interleukin-6 (IL-6) and IL-1, are significantly elevated in CRC patients [53–55], which could have an important role in supporting CCSCs [56, 57]. The gene discussed is IL6; the disease is colorectal carcinoma.